Patient number | Age (years) | Adverse effect | Liver condition | Tx time (months) | Peak CK (U/L) | Peak lactate (mmol/L) | Prognosis | Reference |
---|---|---|---|---|---|---|---|---|
1 | 27 | Myopathy | CHB | 3 | 3243 | – | Resolved | [4] |
2 | 67 | Myopathy | CHB | 20 | 4775 | – | Resolved | [14] |
3 | 25 | Myopathy | CHB | 6 | 1614 | – | Resolved | [15] |
4 | 28 | Myopathy | CHB | 9 | 788 | – | Resolved | [16] |
5 | 25 | Myopathy | CHB | 13 | 2992 | – | Resolved | [16] |
6 | 68 | Myopathy | CHB | 2 | 237 | – | Resolved | [17] |
7 | 35 | Rhabdomyolysis, lactic acidosis | CHB | 11 | 3683 | > 12.0 | Resolved | [6] |
8 | 26 | lactic acidosis | CHB | 12 | 4151 | 11.3 | Resolved | [18] |
9 | 30 | Rhabdomyolysis, lactic acidosis, organ failure | CHB | 11 | 8050 | > 20.0 | Resolved | This paper |
10 | 48 | Rhabdomyolysis, metabolic acidosis, organ failure | Cirrhosis | 9 | 3246 | – | Death | [5] |